Evaluating a hepatitis c quality gap: missed opportunities for HCV-related cares

Yang Liu, Renee H Lawrence, Yngve Falck-Ytter

  • 1HIV/Hepatitis Clinical Pharmacy Specialist, Louis Stokes Cleveland VA Medical Center, Pharmacy Service, 10701 East Blvd, Cleveland, OH 44106.

Insights

Many patients with positive hepatitis C antibody (HCVab) tests do not complete viral RNA testing. Healthcare systems must improve HCV diagnosis to ensure timely and accurate patient care.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) diagnosis requires a two-step process: antibody (HCVab) testing followed by viral RNA testing.
  • A significant care gap exists for individuals with positive HCVab results who do not complete confirmatory viral RNA testing, leaving their HCV status undetermined.

Purpose of the Study:

  • To investigate the extent of HCV-related care provided to patients within this diagnostic care gap.
  • To describe provider acknowledgment of positive HCVab results and subsequent clinical actions taken.

Main Methods:

  • Retrospective cohort study analyzing electronic medical records (EMRs) of patients with positive HCVab tests who did not complete viral RNA testing.
  • Reviewed EMRs for provider acknowledgment of positive HCVab results, documentation of chronic HCV diagnosis, and performance of clinical actions within one year.

Main Results:

  • Provider acknowledgment of positive HCVab results was missing in 31% of subjects.
  • Chronic HCV was added to the problem list in 35% of cases, increasing subsequent documentation.
  • Among patients with recommended actions, 45% received HCV education and 42% had liver enzyme monitoring.

Conclusions:

  • Healthcare systems must optimize the HCV diagnostic pathway to ensure accurate and timely diagnosis.
  • Addressing the care gap in HCV testing is crucial for patient well-being, especially with improved treatments available.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
74
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
17
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
550
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
872